APA (7th ed.) Citation

KM, S., TH, D., & M, R. (2023). ASO Author Reflections: PIPAC Oxaliplatin in Refractory Colorectal or Appendiceal Carcinomatosis: Encouraging Results from a Phase 1 Clinical Trial. Annals of surgical oncology, 30(12), 7860. https://doi.org/10.1245/s10434-023-14067-1

Chicago Style (17th ed.) Citation

KM, Sullivan, Dellinger TH, and Raoof M. "ASO Author Reflections: PIPAC Oxaliplatin in Refractory Colorectal or Appendiceal Carcinomatosis: Encouraging Results from a Phase 1 Clinical Trial." Annals of Surgical Oncology 30, no. 12 (2023): 7860. https://doi.org/10.1245/s10434-023-14067-1.

MLA (9th ed.) Citation

KM, Sullivan, et al. "ASO Author Reflections: PIPAC Oxaliplatin in Refractory Colorectal or Appendiceal Carcinomatosis: Encouraging Results from a Phase 1 Clinical Trial." Annals of Surgical Oncology, vol. 30, no. 12, 2023, p. 7860, https://doi.org/10.1245/s10434-023-14067-1.